Patent · US Active

Hydroxyethylstarch

US7863260B2 · kind B2 · utility

1Cited by

7References

52Claims

0Family size

Assignee

B. Braun Melsungen AG · DE

Inventors

Michael Boll · Homberg (Efze), DE
Andreas Fisch · Lausanne, CH
Donat R. Spahn · Zürich, CH

Key dates

Filing date	Mar 1, 2005
Grant date	Jan 4, 2011
Priority date	—
Expiry date	Apr 9, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08L3/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.